AAAAAA
Results: 1-25/37
Authors:
Owen, WF
Coladonato, J
Szczech, L
Reddan, D
Citation: Wf. Owen et al., Explaining counter-intuitive clinical outcomes predicted by Kt/V, SEMIN DIAL, 14(4), 2001, pp. 268-270
Authors:
Hou, FF
Reddan, DN
Seng, WK
Owen, WF
Citation: Ff. Hou et al., Pathogenesis of beta(2)-microglobulin amyloidosis: Role of monocytes/macrophages, SEMIN DIAL, 14(2), 2001, pp. 135-139
Authors:
Winkelmayer, WC
Glynn, RJ
Levin, R
Owen, WF
Avorn, J
Citation: Wc. Winkelmayer et al., Determinants of delayed nephrologist referral in patients with chronic kidney disease, AM J KIDNEY, 38(6), 2001, pp. 1178-1184
Authors:
Charytan, C
Kaplan, AA
Paganini, EP
Weiss, J
Owen, WF
Citation: C. Charytan et al., Role of the nephrologist in the intensive care unit, AM J KIDNEY, 38(2), 2001, pp. 426-429
Authors:
Reddan, DN
Marcus, RJ
Owen, WF
Szczech, LA
Landwehr, DM
Citation: Dn. Reddan et al., Long-term outcomes of revascularization for peripheral vascular disease inend-stage renal disease patients, AM J KIDNEY, 38(1), 2001, pp. 57-63
Authors:
Reddan, DN
Owen, WF
Citation: Dn. Reddan et Wf. Owen, IgA nephropathy and inhibitors of the renin angiotensin system: Is reduction in proteinuria adequate proof of efficacy?, AM J KIDNEY, 38(1), 2001, pp. 182-185
Authors:
Lacson, E
Teng, M
Lazarus, JM
Lew, N
Lowrie, EG
Owen, WF
Citation: E. Lacson et al., Calculation and public use of the unit-specific standardized mortality ratio - In reply, AM J KIDNEY, 38(1), 2001, pp. 215-217
Authors:
McClellan, WM
Frankenfield, DL
Wish, JB
Rocco, MV
Johnson, CA
Owen, WF
Citation: Wm. Mcclellan et al., Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 end-stagerenal disease core indicators project, AM J KIDNEY, 37(5), 2001, pp. NIL_23-NIL_30
Authors:
Nissenson, AR
Collins, AJ
Dickmeyer, J
Litchfield, T
Mattern, W
McMahill, CN
Muhlbaier, L
Nielsen, J
Owen, WF
Pereira, BJG
Steinman, TI
Szczech, L
Citation: Ar. Nissenson et al., Evaluation of disease-state management of dialysis patients, AM J KIDNEY, 37(5), 2001, pp. 938-944
Authors:
Lacson, E
Teng, M
Lazarus, JM
Lew, N
Lowrie, EG
Owen, WF
Citation: E. Lacson et al., Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis, AM J KIDNEY, 37(2), 2001, pp. 267-275
Authors:
Eknoyan, G
Levin, NW
Eschbach, JW
Golper, TA
Owen, WF
Schwab, S
Steinberg, EP
Citation: G. Eknoyan et al., Continuous quality improvement: DOQI becomes K/DOQI and is updated, AM J KIDNEY, 37(1), 2001, pp. 179-180
Authors:
Owen, WF
Citation: Wf. Owen, Hemodialysis adequacy, AM J KIDNEY, 37(1), 2001, pp. 181-188
Authors:
Levin, NW
Owen, WF
Citation: Nw. Levin et Wf. Owen, Urban Renal Disease - Introduction, SEM NEPHROL, 21(4), 2001, pp. 327-328
Authors:
Ramirez, SPB
Hsu, SIH
Nandakumar, M
Friedman, EA
Durai, TT
Owen, WF
Citation: Spb. Ramirez et al., Funding ESRD care through charity: The paradigm of the National Kidney Foundation of Singapore, SEM NEPHROL, 21(4), 2001, pp. 411-418
Authors:
Reddan, D
Szczech, LA
Conlon, PJ
Owen, WF
Citation: D. Reddan et al., Contextual issues in comparing outcomes and cave processes for ESRD patients around the world, BLOOD PURIF, 19(2), 2001, pp. 152-156
Authors:
Lowrie, EG
Teng, M
Lacson, E
Lew, N
Lazarus, JM
Owen, WF
Citation: Eg. Lowrie et al., Association between prevalent care process measures and facility-specific mortality rates, KIDNEY INT, 60(5), 2001, pp. 1917-1929
Authors:
Szczech, LA
Reddan, DN
Owen, WF
Califf, R
Racz, M
Jones, RH
Hannan, EL
Citation: La. Szczech et al., Differential survival after coronary revascularization procedures among patients with renal insufficiency, KIDNEY INT, 60(1), 2001, pp. 292-299
Authors:
Ameer, GA
Grovender, EA
Ploegh, H
Ting, D
Owen, WF
Rupnick, M
Langer, R
Citation: Ga. Ameer et al., A novel immunoadsorption device for removing beta(2)-microglobulin from whole blood, KIDNEY INT, 59(4), 2001, pp. 1544-1550
Authors:
Hou, FF
Miyata, T
Boyce, J
Yuan, Q
Chertow, GM
Kay, J
Schmidt, AM
Owen, WF
Citation: Ff. Hou et al., beta(2)-microglobulin modified with advanced glycation end products delaysmonocyte apoptosis, KIDNEY INT, 59(3), 2001, pp. 990-1002
Authors:
Szczech, LA
Lowrie, EG
Li, ZS
Lew, NL
Lazarus, JM
Owen, WF
Citation: La. Szczech et al., Changing hemodialysis thresholds for optimal survival, KIDNEY INT, 59(2), 2001, pp. 738-745
Authors:
Rocco, MV
Frankenfield, DL
Frederick, PR
Pugh, J
McClellan, WM
Owen, WF
Citation: Mv. Rocco et al., Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: Results from the 1997 ESRD Core Indicators project, PERIT DIA I, 20(3), 2000, pp. 328-335
Authors:
Reddan, DN
Szczech, LA
Klassen, PS
Owen, WF
Citation: Dn. Reddan et al., Racial inequity in America's ESRD program, SEMIN DIAL, 13(6), 2000, pp. 399-403
Authors:
Hou, FF
Boyce, J
Zhang, Y
Owen, WF
Citation: Ff. Hou et al., Phenotypic and functional characteristics of macrophage-like cells differentiated in pro-inflammatory cytokine-containing cultures, IMM CELL B, 78(3), 2000, pp. 205-213
Authors:
Szczech, LA
Reddan, DN
Lowrie, EG
Owen, WF
Citation: La. Szczech et al., Dose of hemodialysis and survival: can we trust important outcomes to a flawed measure?, INT J ARTIF, 23(7), 2000, pp. 411-414
Authors:
Steinberg, EP
Eknoyan, G
Levin, NW
Eschbach, JW
Golper, TA
Owen, WF
Schwab, S
Citation: Ep. Steinberg et al., Methods used to evaluate the quality of evidence underlying the National Kidney Foundation Dialysis Outcomes Quality Initiative clinical practice guidelines: Description, findings, and implications, AM J KIDNEY, 36(1), 2000, pp. 1-11